Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions

Heart Diseases Clinical Trial

Official title:

Development of a Culturally Tailored Resilience-Building Intervention to Facilitate Advance Care Planning Discussions Between Chinese American Patients and Their Family Caregivers

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06247215
• Other study ID #: 2023-0354
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 15, 2024
• Est. completion date: March 31, 2025

Study information

• Verified date: May 2024
• Source: University of Illinois at Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Less than 15% of Chinese Americans complete advance directives. That is less than half of the 37% completion rate in the US general population. This disparity in the use of advance care planning between White Americans and Chinese Americans may extend to disparities in end-of-life care. To address such disparities in end-of-life care, we will develop and assess the acceptability of a culturally tailored resilience-building intervention to help Chinese Americans with cancer or heart disease and their family caregivers engage in advance care planning discussions.

Description:

The overall objective of this cross-sectional pilot study is to develop a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease in Chicago. A qualitative analysis of semi-structured interviews will be conducted to identify how religious leaders addressed death-related topics with Chinese Americans with cancer or heart disease in Chicago. In addition, a usability test of a resilience-building intervention prototype will be conducted to to understand the feasibility and acceptability among 18 pairs of Chinese Americans and their family caregivers (9 pairs with cancer and 9 pairs with heart disease).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 36
• Est. completion date: March 31, 2025
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion criteria for patient participants:

• Age = 18 years of age
• Having a cancer diagnosis or a heart failure diagnosis documented in the electronic medical record
• Being able to read and respond to questions in English or Mandarin
• Having a family caregiver who is responsible for the care and willing to participate in the study
• Being of non-Hispanic Asian race/ethnicity

Exclusion criteria for patient participants:

• Having cognitive impairment per a Short Portable Mental Status Questionnaire with more than 3 errors
• Having received heart transplantation or a left ventricular assist device • Having completed an advance directive
• Being born in the US

Inclusion criteria for identified family caregivers:

• Age = 18 years
• Being able to read and respond to questions in English or Mandarin
• Being identified by the patient as a family caregiver

Related Conditions & MeSH terms

• Advance Care Planning
• Heart Diseases
• Neoplasms

Intervention

Behavioral:
• Culturally tailored resilience-building intervention
A booklist teaching resilience skills for advance care planning discussions

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
University of Illinois at Chicago	Rush University Medical Center, University of Chicago

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptability	The Theoretical Framework of Acceptability, which ranges from 1 to 5, will be used to assess acceptability. A higher score indicates higher acceptability.	Immediately at the end of the usability testing